Editor’s Note August 8, 2011

We recently introduced OneMedRadio a product designed to bring our readers interviews with the CEOs and investors building some of the most innovative companies in the world of health and medicine. Our focus is on, what we call, “discovery” companies. Typically, these are firms with little or no research coverage, little visibility and are often significantly undervalued. Learn about the firms we follow.  Many of these firms are provided research coverage and will appear at the 5th Annual OneMedForum,  January 9-12th in San Francisco. Mark your calendar.

With this issue we bring you an in depth interview with Jun Ma, Ph.D, the President and CEO of Vasomedical, listed on the PINK  SHEETS as VASO. This, almost forgotten, company has resurrected itself with a new management team, new FDA approvals for ambulatory cardiac monitors, and growing acceptance that their counterpulsation EECP therapy is a low cost alternative to surgery for those with chronic heart conditions.  Read Story…

Also in this issue:

OneMedPlace announces 5th Annual OneMedForum 2012. Bacterin [AMEX:BONE]  IntelliCell BioSciences[OTCQB:SVFC]

The comments are closed.